Literature DB >> 3026374

Evidence that neomycin inhibits HSV 1 infection of BHK cells.

N Langeland, L Haarr, H Holmsen.   

Abstract

The effect of neomycin on the Herpes Simplex Virus (HSV) type 1 and 2 infection of baby hamster kidney cells was studied. Neomycin concentrations of 3 mM or more caused a more than 90% inhibition of HSV 1 proliferation, while it had no effect on HSV 2 proliferation, measured as plaque-forming units. Furthermore, neomycin must be present at the time of infection in order to exert full effect, addition 1 hour postinfection was comparable to untreated cells. This indicates that neomycin may specifically interfere with very early stages of HSV 1 infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026374     DOI: 10.1016/s0006-291x(86)80354-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor.

Authors:  N Langeland; H Holmsen; J R Lillehaug; L Haarr
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  The transduction of mechanical force into biochemical events in bone cells may involve activation of phospholipase A2.

Authors:  I Binderman; U Zor; A M Kaye; Z Shimshoni; A Harell; D Sömjen
Journal:  Calcif Tissue Int       Date:  1988-04       Impact factor: 4.333

3.  Neomycin does not interfere with the inositol phospholipid metabolism, but blocks binding of alpha-thrombin to intact human platelets.

Authors:  O B Tysnes; E Johanessen; V M Steen
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

4.  Antiviral activity of geneticin against dengue virus.

Authors:  Xianchao G Zhang; Peter W Mason; Edward J Dubovi; Xiaodong Xu; Nigel Bourne; Randall W Renshaw; Timothy M Block; Alexander V Birk
Journal:  Antiviral Res       Date:  2009-03-11       Impact factor: 5.970

5.  Reduced yield of infectious pseudorabies virus and herpes simplex virus from cell lines producing viral glycoprotein gp50.

Authors:  E A Petrovskis; A L Meyer; L E Post
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

Review 6.  Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery.

Authors:  Leena Abdulaziz; Esraa Elhadi; Ejlal A Abdallah; Fadlalbaseer A Alnoor; Bashir A Yousef
Journal:  J Exp Pharmacol       Date:  2022-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.